Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
Evaluation of the safety and effectiveness of malaria intermittent chemotherapy and iron
supplementation delivered through Expanded Programme on Immunisation vaccination clinics.
Phase:
N/A
Details
Lead Sponsor:
Gates Malaria Partnership London School of Hygiene and Tropical Medicine
Collaborators:
Department for International Development, United Kingdom INDEPTH Network Kintampo Health Research Centre, Ghana London School of Hygiene and Tropical Medicine Navrongo Health Research Centre, Navrongo, Ghana.
Treatments:
Fanasil, pyrimethamine drug combination Pyrimethamine Sulfadoxine